<DOC>
	<DOCNO>NCT01114958</DOCNO>
	<brief_summary>This phase I study proposes use systemic thiosulfate rescue allow supradose intra-arterial cisplatin delivery lung tumor . Eligible patient would least one lung lesion large enough characterize angiographically . All patient first undergo CT arteriogram target tumor . Patients receive 2 treatment 2 consecutive week . The primary endpoint toxicity , secondary endpoint response measure week 4 . This pilot study also determine technically feasible locate blood supply tumor deliver cisplatin . If first 6 patient well , 6 additional patient accrue total 12 .</brief_summary>
	<brief_title>Pilot Study Intra-Arterial Cisplatin With IV Thiosulfate Patients With Lung Cancer Lung Metastases</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Primary lung cancer ( type ) dominant lung metastasis primary cancer . Patients must either measurable evaluable disease . Karnofsky performance status â‰¥ 70 % . Greater 18 year age . Life expectancy &gt; 3 month . 3 week elapse previous cytotoxic therapy ( except erlotinib hormonal therapy , ongoing ) side effect improve grade 2 less , prior radiotherapy lung . Adequate organ function . Treated brain metastasis , present , toxicity improve grade 2 less . Willingness ability sign write informed consent . Prior radiation large lesion lung . Current pregnancy breastfeeding . Unwillingness inability practice contraception . Renal insufficiency . Comorbidities grade 3 great . Concurrent medical psychiatric condition define treat physician would preclude safe performance study procedure compromise ability patient consent study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Lung cancer</keyword>
	<keyword>Non-small cell lung cancer</keyword>
	<keyword>Small-cell lung cancer</keyword>
	<keyword>Lung metastasis</keyword>
	<keyword>Metastatic cancer</keyword>
	<keyword>Stage IIIA</keyword>
	<keyword>Stage IIIB</keyword>
	<keyword>Stage III</keyword>
	<keyword>Stage 3</keyword>
</DOC>